Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Prolonged expiratory time constant and risk of moderate-to-severe exacerbations in stable COPD
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 15 February 2026

Prolonged expiratory time constant and risk of moderate-to-severe exacerbations in stable COPD

  • Eun-Tae Jeon1 na1,
  • Dong Hyun Kim2 na1,
  • Heemoon Park3,
  • Jung-Kyu Lee3,
  • Eun Young Heo3,
  • Chang Hoon Lee4,
  • Deog Kyeom Kim3 &
  • …
  • Hyun Woo Lee3 

Scientific Reports , Article number:  (2026) Cite this article

  • 448 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Diseases
  • Health care
  • Medical research
  • Risk factors

Abstract

Spirometry provides limited insight into small airway dysfunction in COPD, and evaluation of physiologic parameters such as the expiratory time constant (Tc) may offer complementary information for risk assessment. This retrospective cohort study included 1479 patients with COPD from two tertiary hospitals who underwent baseline chest computed tomography and post-bronchodilator spirometry between 2014 and 2023, with at least five years of follow-up. The Tc was computed from volume-time curves via standardized image analysis. The primary outcome was moderate-to-severe exacerbation. Subgroup analyses were conducted based on symptom severity, airflow limitation, emphysema extent, and airway wall thickness. A prolonged Tc was independently associated with an increased risk of moderate-to-severe exacerbations (adjusted hazard ratio, 1.188; 95% confidence interval, 1.028–1.373). This association was particularly evident in dyspneic patients and was more pronounced among those without a prior history of frequent exacerbations. Consistent patterns of association were observed across subgroups characterized by increased airway wall thickness, preserved diffusing capacity, and lower emphysema burden, corresponding to airway-predominant features. A threshold of 1.14 s was identified, above which the risk of exacerbation was significantly elevated. The Tc may improve individualized risk stratification by identifying patients with COPD who are at increased risk of exacerbations, even in the absence of prior exacerbation history or before the development of advanced parenchymal destruction.

Data availability

The datasets generated and/or analysed during the current study are not publicly available to maintain patient confidentiality and comply with ethical guidelines but are available from the corresponding author on reasonable request.

Abbreviations

AE-COPD:

Acute exacerbation of chronic obstructive pulmonary disease

ATS:

American thoracic society

BMI:

Body mass index

CCI:

Charlson comorbidity index

CI:

Confidence interval

COPD:

Chronic obstructive pulmonary disease

CT:

Computed tomography

DLCO:

Diffusing capacity of the lung for carbon monoxide

Tc:

Expiratory time constant

FEF25–75:

Forced expiratory flow at 25% to 75% of forced vital capacity

FEV1 :

Forced expiratory volume in 1 s

FVC:

Forced vital capacity

HU:

Hounsfield unit

ICS:

Inhaled corticosteroid

IPTW:

Inverse probability of treatment weighting

IQR:

Interquartile range

LAA:

Low attenuation area

LAMA:

Long-acting muscarinic antagonist

mMRC:

Modified medical research council

NLR:

Neutrophil-to-lymphocyte ratio

Pi10:

Square root of airway wall area for a theoretical airway with internal perimeter of 10 mm

SD:

Standard deviation

STROBE:

Strengthening the reporting of observational studies in epidemiology

References

  1. World Health Organization. Chronic obstructive pulmonary disease (COPD) (2023). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 31 March 2025.

  2. Safiri, S. et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. Bmj 378, e069679 (2022).

    Google Scholar 

  3. Putcha, N., Drummond, M. B., Wise, R. A. & Hansel, N. N. Comorbidities and chronic obstructive pulmonary disease: Prevalence, influence on Outcomes, and management. Semin Respir Crit. Care Med. 36 (4), 575–591 (2015).

    Google Scholar 

  4. Anzueto, A., Sethi, S. & Martinez, F. J. Exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 4 (7), 554–564 (2007).

    Google Scholar 

  5. Higham, A., Quinn, A. M., Cançado, J. E. D. & Singh, D. The pathology of small airways disease in COPD: historical aspects and future directions. Respir Res. 20 (1), 49 (2019).

    Google Scholar 

  6. Hoesterey, D. et al. Spirometric indices of early airflow impairment in individuals at risk of developing COPD: spirometry beyond FEV(1)/FVC. Respir Med. 156, 58–68 (2019).

    Google Scholar 

  7. Hess, D. R. Respiratory mechanics in mechanically ventilated patients. Respir Care. 59 (11), 1773–1794 (2014).

    Google Scholar 

  8. Bodduluri, S., Nakhmani, A., Bhatt, S. & EARLY COPD AND BEYOND. Spirometric time Constant for Detection of Early and Mild Airflow Obstruction. B93 EARLY DISEASE TRAJECTORIES: PRISM, PRE-COPD p. A4680–A (American Thoracic Society, 2024).

  9. Hogg, J. C., Paré, P. D. & Hackett, T. L. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol. Rev. 97 (2), 529–552 (2017).

    Google Scholar 

  10. Martins, C., Barros, H. & Moreira, A. Transfer learning in spirometry: CNN models for automated flow-volume curve quality control in paediatric populations. Comput. Biol. Med. 184, 109341 (2025).

    Google Scholar 

  11. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [ (2025). http://www.goldcopd.org/ Accessed January 31, 2025].

  12. Adibi, A. et al. The acute COPD exacerbation prediction tool (ACCEPT): a modelling study. Lancet Respir Med. 8 (10), 1013–1021 (2020).

    Google Scholar 

  13. Guerra, B., Gaveikaite, V., Bianchi, C. & Puhan, M. A. Prediction models for exacerbations in patients with COPD. Eur. Respir Rev. ;26(143). (2017).

  14. Chaudhary, M. F. A. et al. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study. Lancet Digit. Health. 5 (2), e83–e92 (2023).

    Google Scholar 

  15. Kim, D. H. et al. Longitudinal changes in maximal forced inspiratory flow and clinical outcomes in patients with COPD. Chest 167 (1), 76–86 (2025).

    Google Scholar 

  16. Park, H. et al. Diffusing capacity as an independent predictor of acute exacerbations in chronic obstructive pulmonary disease. Sci. Rep. 14 (1), 2936 (2024).

    Google Scholar 

  17. Jeon, E-T. et al. Deep Learning–Based chronic obstructive pulmonary disease exacerbation prediction using Flow-Volume and Volume-Time curve imaging: retrospective cohort study. J. Med. Internet. Res. 27, e69785 (2025).

    Google Scholar 

  18. Henderson, W. R. et al. Effect of tidal volume and positive end-expiratory pressure on expiratory time constants in experimental lung injury. Physiol. Rep. ;4(5). (2016).

  19. Wiriyaporn, D., Wang, L. & Aboussouan, L. S. Expiratory time constant and sleep apnea severity in the overlap syndrome. J. Clin. Sleep. Med. 12 (3), 327–332 (2016).

    Google Scholar 

  20. Lourens, M. S. et al. Expiratory time constants in mechanically ventilated patients with and without COPD. Intensive Care Med. 26 (11), 1612–1618 (2000).

    Google Scholar 

  21. Crisafulli, E. et al. Prevalence of Small-Airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration 93 (1), 32–41 (2017).

    Google Scholar 

  22. Beech, A., Jackson, N., Dean, J. & Singh, D. Expiratory flow limitation in a cohort of highly symptomatic COPD patients. ERJ Open. Res. ;8(2). (2022).

  23. Pisi, R. et al. Ventilation heterogeneity in asthma and COPD: the value of the poorly communicating fraction as the ratio of total lung capacity to alveolar volume. Respiration 100 (5), 404–410 (2021).

    Google Scholar 

  24. Jin, K. N. et al. Mucus plugs as precursors to exacerbation and lung function decline in COPD patients. Arch. Bronconeumol. 61 (3), 138–146 (2025).

    Google Scholar 

  25. Lee, H. W. et al. Spirometric interpretation and clinical relevance according to different reference equations. J. Korean Med. Sci. 39 (4), e20 (2024).

    Google Scholar 

  26. von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 4 (10), e296 (2007).

    Google Scholar 

  27. Global Initiative for Asthma. The Global Strategy for Asthma Management and Prevention [ (2025). https://ginasthma.org/gina-reports/ Accessed July 15 2025].

  28. Wanger, J. et al. Standardisation of the measurement of lung volumes. Eur. Respir J. 26 (3), 511–522 (2005).

    Google Scholar 

  29. Bowerman, C. et al. A Race-neutral approach to the interpretation of lung function measurements. Am. J. Respir Crit. Care Med. 207 (6), 768–774 (2023).

    Google Scholar 

  30. Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir J. 40 (6), 1324–1343 (2012).

    Google Scholar 

  31. Stanojevic, S. et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur. Respir J. ;50(3). (2017).

  32. Hu, P., Han, Y., Zhang, Z., Chu, S-C. & Pan, J-S. A multi-level thresholding image segmentation algorithm based on equilibrium optimizer. Sci. Rep. 14 (1), 29728 (2024).

    Google Scholar 

  33. Pereira Neto, A. & Barros, F. J. Noise reduction in brain magnetic resonance imaging using adaptive wavelet thresholding based on linear prediction factor. Front. NeuroSci. 18, 1516514 (2025).

    Google Scholar 

Download references

Funding

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : RS-2021-KH114109).

Author information

Author notes
  1. These authors contributed equally: Eun-Tae Jeon and Dong Hyun Kim.

Authors and Affiliations

  1. Department of Neurology, Korea University Ansan Hospital, University College of Medicine, Ansan, South Korea

    Eun-Tae Jeon

  2. Department of Radiology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, South Korea

    Dong Hyun Kim

  3. Division of Respiratory and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul, Republic of Korea

    Heemoon Park, Jung-Kyu Lee, Eun Young Heo, Deog Kyeom Kim & Hyun Woo Lee

  4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea

    Chang Hoon Lee

Authors
  1. Eun-Tae Jeon
    View author publications

    Search author on:PubMed Google Scholar

  2. Dong Hyun Kim
    View author publications

    Search author on:PubMed Google Scholar

  3. Heemoon Park
    View author publications

    Search author on:PubMed Google Scholar

  4. Jung-Kyu Lee
    View author publications

    Search author on:PubMed Google Scholar

  5. Eun Young Heo
    View author publications

    Search author on:PubMed Google Scholar

  6. Chang Hoon Lee
    View author publications

    Search author on:PubMed Google Scholar

  7. Deog Kyeom Kim
    View author publications

    Search author on:PubMed Google Scholar

  8. Hyun Woo Lee
    View author publications

    Search author on:PubMed Google Scholar

Contributions

Study concept and design: H.W.L.Acquisition of data: E.T.J., D.H.K., H.W.L.Analysis and interpretation of data: E.T.J., D.H.K., H.W.L.Drafting the manuscript: E.T.J., D.H.K.Critical revision of the manuscript and important intellectual content: H.P., J.K.L., E.Y.H., C.H.L., D.K.K., H.W.L.Study supervision: H.W.L.

Corresponding author

Correspondence to Hyun Woo Lee.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study was conducted in accordance with the Declaration of Helsinki and received approval from the Institutional Review Board of the Seoul Metropolitan Government-Seoul National University (SMG-SNU) Boramae Medical Center (IRB no. 20-2023-11). The requirement for written informed consent was waived due to the retrospective nature of the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jeon, ET., Kim, D.H., Park, H. et al. Prolonged expiratory time constant and risk of moderate-to-severe exacerbations in stable COPD. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39987-2

Download citation

  • Received: 12 September 2025

  • Accepted: 09 February 2026

  • Published: 15 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-39987-2

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Chronic obstructive pulmonary disease
  • Expiratory time constant
  • Spirometry
  • Exacerbation risk
  • Risk stratification
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing